Tiny stem cell companies close in on major heart disease goals – Reuters
Reuters |
Tiny stem cell companies close in on major heart disease goals
Reuters They are among the farthest along in the stem cell industry at a time when Wall Street investors have focused on potentially big payoffs from immune-system based cancer therapies and rare disease treatments. Perception of the field has also been hurt … |
